12047324

Source:http://linkedlifedata.com/resource/pubmed/id/12047324

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0033417, umls-concept:C0079488, umls-concept:C0087111, umls-concept:C0442796, umls-concept:C1280500
pubmed:issue	3
pubmed:dateCreated	2002-6-5
pubmed:abstractText	Helicobacter pylori (H. pylori) colonizes not only the surface of the surface mucous cells but also the surface mucous gel layer (SMGL). Thus, we examined the possible value of pronase, a mucolytic agent, as a potential eradication therapy.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12047324-12603620
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9605411
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo..., http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Metronidazole, http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole, http://linkedlifedata.com/resource/pubmed/chemical/Pronase, http://linkedlifedata.com/resource/pubmed/chemical/lansoprazole
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1083-4389
pubmed:author	pubmed-author:AkamatsuTaijiT, pubmed-author:GotohAkiraA, pubmed-author:IkenoTatsuoT, pubmed-author:IshidaKimitakaK, pubmed-author:KanekoTaimeiT, pubmed-author:KatsuyamaTsutomuT, pubmed-author:KawakamiYoshiyukiY, pubmed-author:KiyosawaKendoK, pubmed-author:OtaHiroyoshiH, pubmed-author:ShimizuToshikiT, pubmed-author:ShimodairaKazuhisaK, pubmed-author:SugiyamaAtsushiA
pubmed:issnType	Print
pubmed:volume	7
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	183-91
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:12047324-2-Pyridinylmethylsulfinylbenzimidazoles, pubmed-meshheading:12047324-Adolescent, pubmed-meshheading:12047324-Adult, pubmed-meshheading:12047324-Aged, pubmed-meshheading:12047324-Amoxicillin, pubmed-meshheading:12047324-Anti-Bacterial Agents, pubmed-meshheading:12047324-Drug Therapy, Combination, pubmed-meshheading:12047324-Female, pubmed-meshheading:12047324-Gastric Mucosa, pubmed-meshheading:12047324-Gastritis, pubmed-meshheading:12047324-Helicobacter Infections, pubmed-meshheading:12047324-Helicobacter pylori, pubmed-meshheading:12047324-Humans, pubmed-meshheading:12047324-Male, pubmed-meshheading:12047324-Metronidazole, pubmed-meshheading:12047324-Microbial Sensitivity Tests, pubmed-meshheading:12047324-Middle Aged, pubmed-meshheading:12047324-Omeprazole, pubmed-meshheading:12047324-Pronase, pubmed-meshheading:12047324-Treatment Outcome
pubmed:year	2002
pubmed:articleTitle	Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori.
pubmed:affiliation	The Second Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial